课题基金 / 基金详情

ROLE OF PROTO-ONCOGENES IN CELLULAR PROLIFERATION

ROLE OF PROTO-ONCOGENES IN CELLULAR PROLIFERATION
原癌基因在细胞增殖中的作用
批准号:
3192579
负责人:
DENNIS W STACEY
金额:
$18.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 1994-05-31

项目摘要

项目成果

DENNIS W STACEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Proto-oncogenes play a critical role in the regulation of cell growth, but it has been difficult to relate the structure of these molecules to their biological functions within the cell.. The goal of this proposal is to determine the role of several critical proto-oncogenes in the control of cell division. In past work a neutralizing antibody to the proto-oncogene ras was identified and microinjected into living cells. The consequences of this treatment upon the proliferative capacity of the cell then indicated the function of ras proteins in normal proliferation. It was clear not only that cellular ras proteins were critical for proliferation, but that ras activity was essential to the function of some but not all retroviral oncogenes. On the basis of these results we have suggested that ras proteins might function to transmit a proliferative signal from one class of proto-oncogenes to another, and that phospholipid metabolism is involved in this signalling. The objective of this proposal is to test these critical hypotheses. First, neutralizing antibodies to other proto-oncogenes believed to function at different stages of the postulated signal transduction pathway will be produced and tested. These antibodies will allow a direct test of the hypothesis that various proto-oncogenes function together in a signal transduction pathway. In addition, previous studies with the anti-ras antibody suggested that phospholipid metabolism might be involved in regulating the biological activity of ras proteins. Recent studies have provided direct biochemical evidence that this might be the case. If these results can be verified and expanded it might provide the first indication of how the activity of cellular ras proteins might be controlled during mitogenesis. The second objective of the proposed study is, therefore, to verify and expand these initial studies. The importance of this work is emphasized by the fact that while cellular ras proteins are believed to play a central role in the control of proliferation, no other indication has yet been reported to explain the biological activation of these proteins. Finally, these microinjection and biochemical studies will be placed in a biological context. The action of oncogenes will be placed in temporal relationship to the known biological marker of cell division . These studies constitute a unique approach in the biological analysis of proliferative genes. the information obtained will undoubtedly aid directly in a molecular understanding of tumor formation since these genes are among those most often mutated in natural human tumors. Furthermore, the biological markers to be tested included antiproliferative agents commonly utilized in anti-tumor therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of topoisomerose II through the cell cycle
  • 批准号:
    6801025
  • 项目类别:
  • 资助金额:
    $22.22万
  • 财政年份:
    2001
  • 负责人:
    DENNIS W STACEY
  • 依托单位:
Control of topoisomerose II through the cell cycle
  • 批准号:
    6364843
  • 项目类别:
  • 资助金额:
    $21.5万
  • 财政年份:
    2001
  • 负责人:
    DENNIS W STACEY
  • 依托单位:
Control of topoisomerose II through the cell cycle
  • 批准号:
    6515181
  • 项目类别:
  • 资助金额:
    $21.5万
  • 财政年份:
    2001
  • 负责人:
    DENNIS W STACEY
  • 依托单位:
Control of topoisomerose II through the cell cycle
  • 批准号:
    6634084
  • 项目类别:
  • 资助金额:
    $22.22万
  • 财政年份:
    2001
  • 负责人:
    DENNIS W STACEY
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: